• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌放疗后感音神经性听力损失:个体化风险评估

Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.

作者信息

Honoré Henriette B, Bentzen Søren M, Møller Kitty, Grau Cai

机构信息

Department of Medical Physics, Aarhus University Hospital, Nørrebrogade 44, Building 5, DK-8000 Aarhus C, Denmark.

出版信息

Radiother Oncol. 2002 Oct;65(1):9-16. doi: 10.1016/s0167-8140(02)00173-1.

DOI:10.1016/s0167-8140(02)00173-1
PMID:12413669
Abstract

BACKGROUND AND PURPOSE

Sensori-neural hearing loss (SNHL) is a common complication to radiation therapy in the upper head and neck region. In this study, we estimated the dose response relationship for SNHL with adjustment for pre-therapeutic risk factors.

PATIENTS AND METHODS

The pre- and post-therapeutic hearing levels were recorded in a previously published study of 20 patients receiving radiotherapy for nasopharyngeal carcinoma. In the present study, the dose to the inner ear of these patients was estimated with a computed tomography (CT) based treatment planning system. CT data from a 'proxy patient' were used for patients with no available CT scan. SNHL was analyzed as a function of radiation dose and potential risk factors were tested.

RESULTS

The incidence of SNHL increased significantly with increasing dose to the cochlea. Increasing patient's age, and decreasing pre-therapeutic hearing level were statistically significantly associated with an increased risk of SNHL. A nomogram is presented for estimating individualized dose constraints of potential use in treatment planning.

CONCLUSIONS

The inner ear is a critical structure in patients with nasopharyngeal carcinoma and the dose to the inner ear should be carefully considered when planning radiation treatment in this region.

摘要

背景与目的

感音神经性听力损失(SNHL)是头颈部上段放疗常见的并发症。在本研究中,我们在对治疗前危险因素进行校正的情况下估计了SNHL的剂量反应关系。

患者与方法

在一项先前发表的对20例接受鼻咽癌放疗患者的研究中记录了治疗前后的听力水平。在本研究中,使用基于计算机断层扫描(CT)的治疗计划系统估计这些患者内耳的剂量。对于没有可用CT扫描的患者,使用来自“替代患者”的CT数据。分析SNHL作为辐射剂量的函数,并对潜在危险因素进行检测。

结果

SNHL的发生率随耳蜗剂量增加而显著增加。患者年龄增加以及治疗前听力水平降低与SNHL风险增加在统计学上显著相关。给出了一个列线图,用于估计在治疗计划中可能使用的个体化剂量限制。

结论

内耳是鼻咽癌患者的关键结构,在该区域进行放射治疗计划时应仔细考虑内耳的剂量。

相似文献

1
Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.鼻咽癌放疗后感音神经性听力损失:个体化风险评估
Radiother Oncol. 2002 Oct;65(1):9-16. doi: 10.1016/s0167-8140(02)00173-1.
2
Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma.鼻咽癌放疗患者的感音神经性听力损失
Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):723-8. doi: 10.1016/0360-3016(91)90692-w.
3
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.鼻咽癌综合治疗中的感音神经性听力损失
Cancer. 2006 Feb 15;106(4):820-9. doi: 10.1002/cncr.21683.
4
Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.鼻咽癌调强放射治疗5年后与传导性或感音神经性听力损失相关的剂量学参数。
Acta Otolaryngol. 2019 Mar;139(3):263-268. doi: 10.1080/00016489.2019.1566778. Epub 2019 Mar 14.
5
Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.鼻咽癌同步顺铂化疗和放疗后出现的感音神经性听力损失。
Radiother Oncol. 2004 Jul;72(1):79-82. doi: 10.1016/j.radonc.2004.02.009.
6
Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.鼻咽癌患者同期放化疗后感音神经性听力损失。
Radiat Oncol. 2011 Feb 20;6:19. doi: 10.1186/1748-717X-6-19.
7
Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.鼻咽癌患者感音神经性听力损失的长期预后:单纯放疗与放化疗的比较
Cell Biochem Biophys. 2014 Jul;69(3):433-7. doi: 10.1007/s12013-014-9814-x.
8
Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.现代治疗时代鼻咽癌幸存者的感音神经性听力损失——放疗和顺铂的早期及晚期影响
Clin Oncol (R Coll Radiol). 2022 Apr;34(4):e160-e167. doi: 10.1016/j.clon.2021.10.013. Epub 2021 Nov 10.
9
Radiotherapy-induced ear toxicity.放射治疗引起的耳部毒性。
Cancer Treat Rev. 2003 Oct;29(5):417-30. doi: 10.1016/s0305-7372(03)00066-5.
10
Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.鼻咽癌治疗后感音神经性听力损失:一项纵向分析。
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1335-42. doi: 10.1016/j.ijrobp.2008.07.034. Epub 2008 Oct 14.

引用本文的文献

1
Hearing Loss and Middle Ear Effusion in Nasopharyngeal Carcinoma Following Radiotherapy: Dose-Response Relationship and Normal Tissue Complication Probability Modeling.鼻咽癌放疗后听力损失与中耳积液:剂量反应关系及正常组织并发症概率模型
Int Arch Otorhinolaryngol. 2025 Jul 3;29(2):1-9. doi: 10.1055/s-0045-1805045. eCollection 2025 Apr.
2
Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study.髓母细胞瘤患者治疗相关感音神经性听力损失及助听器使用的危险因素:一项观察性队列研究。
Strahlenther Onkol. 2025 Apr;201(4):438-451. doi: 10.1007/s00066-024-02308-5. Epub 2024 Oct 25.
3
Audiological Outcomes of Weekly vs. Triweekly Cisplatin in Head and Neck Cancer with Cochlear-Sparing Intensity-Modulated Radiation Therapy.
每周一次与每三周一次顺铂联合保留耳蜗的调强放射治疗对头颈部癌的听力学结果
Cancers (Basel). 2024 Jun 14;16(12):2228. doi: 10.3390/cancers16122228.
4
COX inhibitor use during definitive radiotherapy is associated with worse hearing preservation in patients with vestibular schwannoma.在明确的放射治疗期间使用 COX 抑制剂与听神经鞘瘤患者的听力保护更差相关。
J Neurooncol. 2023 Oct;165(1):139-148. doi: 10.1007/s11060-023-04462-9. Epub 2023 Oct 27.
5
Effects of Chemoradiation Therapy on Hearing in Patients with Malignancy of Head and Neck.放化疗对头颈恶性肿瘤患者听力的影响。
Indian J Otolaryngol Head Neck Surg. 2023 Sep;75(3):1950-1953. doi: 10.1007/s12070-023-03764-8. Epub 2023 Apr 20.
6
The relevance of ototoxicity induced by radiotherapy.放疗引起耳毒性的相关性。
Radiat Oncol. 2023 Jun 3;18(1):95. doi: 10.1186/s13014-023-02268-7.
7
Radiotherapy-associated Sensorineural Hearing Loss in Pediatric Oncology Patients.儿科肿瘤患者放疗相关的感音神经性听力损失。
Curr Med Chem. 2024;31(33):5351-5369. doi: 10.2174/0929867330666230515112245.
8
Long-Term Outcomes of Fractionated Stereotactic Proton Therapy for Vestibular Schwannoma: A Case Series.前庭神经鞘瘤分次立体定向质子治疗的长期疗效:病例系列研究
Int J Part Ther. 2018 Spring;4(4):37-46. doi: 10.14338/IJPT-17-00032.1. Epub 2018 Jul 26.
9
Hearing Preservation in Stereotactic Radiosurgery for Vestibular Schwannoma.前庭神经鞘瘤立体定向放射外科手术中的听力保留
J Neurol Surg B Skull Base. 2019 Apr;80(2):156-164. doi: 10.1055/s-0039-1677680. Epub 2019 Jan 10.
10
Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.放射技术、放射分次剂量和顺铂总剂量对听力的影响:29例髓母细胞瘤患者的回顾性分析
Strahlenther Onkol. 2017 Nov;193(11):910-920. doi: 10.1007/s00066-017-1205-y. Epub 2017 Sep 8.